Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Ann Surg Oncol. 2019 Dec 10;27(2):344–351. doi: 10.1245/s10434-019-07948-x

TABLE 1.

Patient Characteristics by Surgery Year

Overall (n = 449) NSM before 2011 (n = 105) NSM after 2011 (n = 344) p-value
Median Age, years (range) 45 (24–75) 44 (25–64) 45 (24–75) 0.51
Family History
 Breast Cancer (≥ 1st Degree) 118 (26.3%) 27 (25.7%) 90 (26.2%) 0.90
 Ovarian Cancer (≥ 1st Degree) 11 (2.4%) 6 (5.7%) 5 (1.5%) 0.03a
Genetic Testing 0.07
 No 179 (39.9%) 50 (47.6%) 129 (37.5%)
 Yes 270 (60.1%) 55 (52.4%) 215 (62.5%)
Mutations Detected (n = 270)
 BRCA1 28 (10.4%) 6 (10.9%) 22 (10.2%) 0.81
 BRCA2 18 (6.7%) 5 (9.1%) 13 (6.0%) 0.38
Smoking Status 0.83
 Current Smoker 25 (5.6%) 6 (5.7%) 19 (5.5%)
 Never Smoker 326 (72.6%) 74 (70.5%) 252 (73.3%)
 Former Smoker 98 (21.8%) 25 (23.8%) 73 (21.2%)
Prior Radiation 0.08
 Yes 32 (7.1%) 12 (11.4%) 20 (5.8%)
 No 417 (92.9%) 93 (88.6%) 324 (94.2%)
Preoperative MRI < .00 lb
 Yes 294 (65.5%) 43 (41.0%) 251 (73.0%)
 No 155 (34.5%) 62 (59.0%) 93 (27.0%)
Contralateral Prophylactic NSM 0.63
 Yes 310 (69.0%) 75 (71.4%) 235 (68.3%)
 No 139 (31.0%) 30 (28.6%) 109 (31.7%)

NSM nipple-sparing mastectomy

a

bold increased frequency of family history of ovarian cancer in cases before 2011

b

bold denotes increased use of preoperative MRI